Style | Citing Format |
---|---|
MLA | Vandghanooni S, et al.. "Acriflavine-Loaded Solid Lipid Nanoparticles: Preparation, Physicochemical Characterization, and Anti-Proliferative Properties." Pharmaceutical Development and Technology, vol. 26, no. 9, 2021, pp. 934-942. |
APA | Vandghanooni S, Rasoulian F, Eskandani M, Akbari Nakhjavani S, Eskandani M (2021). Acriflavine-Loaded Solid Lipid Nanoparticles: Preparation, Physicochemical Characterization, and Anti-Proliferative Properties. Pharmaceutical Development and Technology, 26(9), 934-942. |
Chicago | Vandghanooni S, Rasoulian F, Eskandani M, Akbari Nakhjavani S, Eskandani M. "Acriflavine-Loaded Solid Lipid Nanoparticles: Preparation, Physicochemical Characterization, and Anti-Proliferative Properties." Pharmaceutical Development and Technology 26, no. 9 (2021): 934-942. |
Harvard | Vandghanooni S et al. (2021) 'Acriflavine-Loaded Solid Lipid Nanoparticles: Preparation, Physicochemical Characterization, and Anti-Proliferative Properties', Pharmaceutical Development and Technology, 26(9), pp. 934-942. |
Vancouver | Vandghanooni S, Rasoulian F, Eskandani M, Akbari Nakhjavani S, Eskandani M. Acriflavine-Loaded Solid Lipid Nanoparticles: Preparation, Physicochemical Characterization, and Anti-Proliferative Properties. Pharmaceutical Development and Technology. 2021;26(9):934-942. |
BibTex | @article{ author = {Vandghanooni S and Rasoulian F and Eskandani M and Akbari Nakhjavani S and Eskandani M}, title = {Acriflavine-Loaded Solid Lipid Nanoparticles: Preparation, Physicochemical Characterization, and Anti-Proliferative Properties}, journal = {Pharmaceutical Development and Technology}, volume = {26}, number = {9}, pages = {934-942}, year = {2021} } |
RIS | TY - JOUR AU - Vandghanooni S AU - Rasoulian F AU - Eskandani M AU - Akbari Nakhjavani S AU - Eskandani M TI - Acriflavine-Loaded Solid Lipid Nanoparticles: Preparation, Physicochemical Characterization, and Anti-Proliferative Properties JO - Pharmaceutical Development and Technology VL - 26 IS - 9 SP - 934 EP - 942 PY - 2021 ER - |